125 related articles for article (PubMed ID: 35157032)
41. TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.
Barbisan G; Pérez LO; Contreras A; Golijow CD
Tumour Biol; 2012 Oct; 33(5):1549-56. PubMed ID: 22592655
[TBL] [Abstract][Full Text] [Related]
42. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
43. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
44. 14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements.
Allou L; Lambert L; Amsallem D; Bieth E; Edery P; Destrée A; Rivier F; Amor D; Thompson E; Nicholl J; Harbord M; Nemos C; Saunier A; Moustaïne A; Vigouroux A; Jonveaux P; Philippe C
Eur J Hum Genet; 2012 Dec; 20(12):1216-23. PubMed ID: 22739344
[TBL] [Abstract][Full Text] [Related]
45. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
46. Chapter 5: Viral and host factors in human papillomavirus persistence and progression.
Wang SS; Hildesheim A
J Natl Cancer Inst Monogr; 2003; (31):35-40. PubMed ID: 12807943
[TBL] [Abstract][Full Text] [Related]
47. Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population.
Huang SQ; Zhou ZX; Zheng SL; Liu DD; Ye XH; Zeng CL; Han YJ; Wen ZH; Zou XQ; Wu J; Liu YM; Huang CC; Wang Y; Yang G; Jing CX
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29853562
[TBL] [Abstract][Full Text] [Related]
48. An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population.
Feng D; Xu H; Li X; Wei Y; Jiang H; Xu H; Luo A; Zhou F
Tumour Biol; 2016 Apr; 37(4):5599-607. PubMed ID: 26577855
[TBL] [Abstract][Full Text] [Related]
49. Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.
Huang FY; Chiu PM; Tam KF; Kwok YK; Lau ET; Tang MH; Ng TY; Liu VW; Cheung AN; Ngan HY
Gynecol Oncol; 2006 Oct; 103(1):219-25. PubMed ID: 16595147
[TBL] [Abstract][Full Text] [Related]
50. Relationship between GSTM1 and GSTT1 polymorphisms and HPV infection: a systematic review.
Bortolli APR; Vieira VK; Stefanski EE; Lazarotto AK; Lucio LC
Mol Biol Rep; 2021 Sep; 48(9):6631-6636. PubMed ID: 34387803
[TBL] [Abstract][Full Text] [Related]
51. Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis.
Sharma Saha S; Roy Chowdhury R; Mondal NR; Chakravarty B; Chatterjee T; Roy S; Sengupta S
Cell Oncol (Dordr); 2016 Dec; 39(6):559-572. PubMed ID: 27683269
[TBL] [Abstract][Full Text] [Related]
52. An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with Human Papillomavirus and using oral contraceptives.
Chagas BS; Gurgel AP; da Cruz HL; Amaral CM; Cardoso MV; Silva Neto Jda C; da Silva LA; de Albuquerque EM; Muniz MT; de Freitas AC
Infect Genet Evol; 2013 Oct; 19():32-7. PubMed ID: 23800422
[TBL] [Abstract][Full Text] [Related]
53. XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women.
Barbisan G; Pérez LO; Difranza L; Fernández CJ; Ciancio NE; Golijow CD
Eur J Gynaecol Oncol; 2011; 32(3):274-9. PubMed ID: 21797115
[TBL] [Abstract][Full Text] [Related]
54. Genetic susceptibility to HPV infection and cervical cancer.
Maciag PC; Villa LL
Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
[TBL] [Abstract][Full Text] [Related]
55. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
56. Whole exome sequencing identifies a novel 5 Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures.
Vineeth VS; Dutta UR; Tallapaka K; Das Bhowmik A; Dalal A
Gene; 2018 Oct; 673():56-60. PubMed ID: 29920362
[TBL] [Abstract][Full Text] [Related]
57. Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.
Ramachandran D; Wang Y; Schürmann P; Hülse F; Mao Q; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Dörk T
Int J Cancer; 2021 Apr; ():. PubMed ID: 33905146
[TBL] [Abstract][Full Text] [Related]
58. Systematic validation of hypothesis-driven candidate genes for cervical cancer in a genome-wide association study.
Johanneson B; Chen D; Enroth S; Cui T; Gyllensten U
Carcinogenesis; 2014 Sep; 35(9):2084-8. PubMed ID: 24879636
[TBL] [Abstract][Full Text] [Related]
59. Genomic Risk Factors for Cervical Cancer.
Ramachandran D; Dörk T
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680286
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Ramachandran D; Dennis J; Fachal L; Schürmann P; Bousset K; Hülse F; Mao Q; Wang Y; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Stübs F; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Easton DF; Dörk T
Hum Mol Genet; 2022 Aug; 31(15):2483-2497. PubMed ID: 35157032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
